Pyroptosis in lung cancer: The emerging role of non-coding RNAs

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer is a major global health challenge requiring innovative treatments.
• Pyroptosis, an inflammatory programmed cell death, influences cancer progression and treatment outcomes.
• Non-coding RNAs (ncRNAs), including lncRNAs, miRNAs, and circRNAs, play critical roles in cellular processes and oncogenesis.

Purpose of the Study:

• To review current research on the role of ncRNAs in regulating pyroptosis in lung cancer.
• To propose novel therapeutic strategies targeting ncRNA-mediated pyroptosis for lung cancer intervention.
• To explore the potential of ncRNAs as biomarkers for treatment response and overcoming therapy resistance.

Main Methods:

• Literature review integrating recent findings on ncRNAs and pyroptosis pathways.
• Analysis of molecular interactions between ncRNAs and key pyroptosis regulators (e.g., NLRP3, GSDMD).
• Exploration of therapeutic implications and biomarker potential of ncRNAs in lung cancer.

Main Results:

• ncRNAs exhibit a dual role, either promoting or inhibiting pyroptosis by interacting with key molecular players.
• Specific ncRNAs can modulate pyroptosis pathways, presenting therapeutic opportunities.
• ncRNAs show potential as predictive biomarkers for lung cancer treatment response.

Conclusions:

• Targeting ncRNA-mediated pyroptosis represents a promising avenue for novel lung cancer therapies.
• ncRNAs can be leveraged to overcome resistance to conventional lung cancer treatments.
• Further research into ncRNA-pyroptosis interactions could lead to improved diagnostic and therapeutic strategies for lung cancer.